Form 4: Teleflex Executive Granted Equity Awards, Sells Shares for Tax

A Teleflex Inc. corporate vice president received significant equity awards and stock options, while also disposing of shares to cover tax liabilities.

Summary

• James Winters, Corporate VP, Manufacturing and Supply at Teleflex Inc. (TFX), reported several transactions.
• On March 3, 2026, Winters was granted 3,262 shares of common stock as a Restricted Stock Unit (RSU) award, with vesting scheduled at 25% annually from March 3, 2027, through March 3, 2030.
• Also on March 3, 2026, Winters received another RSU award of 9,745 shares of common stock, vesting 50% on March 3, 2027, and 50% on September 3, 2027.
• Winters was granted 21,510 stock options on March 3, 2026, with an exercise price of $122.19 and an expiration date of March 3, 2036. These options vest one-third annually from March 3, 2027, through March 3, 2029.
• On March 4, 2026, 247 shares of common stock were disposed of at a price of $119.18 per share to satisfy tax liabilities upon the vesting of a restricted stock unit award.
• Following these transactions, Winters beneficially owns 17,760 shares of common stock and 21,510 derivative stock options.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting routine executive compensation and retention efforts. The significant equity grants align executive interests with long-term company performance, despite the minor share disposition for tax purposes.

Positives

• James Winters received substantial equity awards, including 13,007 shares of common stock through Restricted Stock Units.
• Winters was granted 21,510 stock options, indicating continued alignment of executive incentives with shareholder value.
• The awards are part of the Teleflex Incorporated 2023 Stock Incentive Plan, suggesting a structured approach to executive compensation.

Negatives

• 247 shares of common stock were disposed of to cover tax liabilities, representing a reduction in direct beneficial ownership.

Risks

• The vesting of equity awards is subject to the reporting person's continuous service to the Issuer, posing a risk of forfeiture if employment ceases.

Future Outlook

The equity awards granted to James Winters include multi-year vesting schedules extending through March 2030 for RSUs and March 2029 for stock options, contingent on his continuous service to Teleflex Inc. This structure aims to incentivize long-term executive retention and performance.

Management Comments

• Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan.
• Shares withheld to satisfy tax liability upon vesting of restricted stock unit award.

Industry Context

StockSavvy.ai notes that the granting of equity awards and stock options to key executives like James Winters is a standard practice in the medical device and healthcare industry. This compensation structure is widely used to align management's interests with those of shareholders, promoting long-term value creation and executive retention in a competitive talent market.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) and stock options with multi-year vesting schedules is a common compensation strategy across the S&P 500, including peers in the medical technology sector such as Medtronic (MDT) and Stryker (SYK).
• The disposition of shares to cover tax liabilities upon RSU vesting is a standard and expected event for equity compensation, reflecting a common practice seen in executive compensation reports from companies like Johnson & Johnson (JNJ) and Abbott Laboratories (ABT).

Stakeholder Impact

• Shareholders: The granting of equity awards to a key executive aligns management's long-term interests with shareholder value creation, potentially fostering sustained performance.
• Employees: The equity incentive plan demonstrates the company's commitment to retaining and incentivizing key personnel, which can positively impact employee morale and stability.

Next Steps

• Continued vesting of 3,262 RSU shares on March 3, 2027, March 3, 2028, March 3, 2029, and March 3, 2030.
• Continued vesting of 9,745 RSU shares on March 3, 2027, and September 3, 2027.
• Continued vesting of 21,510 stock options on March 3, 2027, March 3, 2028, and March 3, 2029.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation, including equity grants and a tax-related share disposition. While positive for executive alignment, it does not present new information that would fundamentally alter the investment thesis for Teleflex Inc. A seasoned investor would likely maintain their current position based on this filing alone, awaiting broader financial or strategic updates.

Keywords

Teleflex, TFX, SEC Form 4, Insider Trading, Restricted Stock Units, Stock Options, Equity Awards, Executive Compensation, Beneficial Ownership